TriRadial Blog

Recent Posts

FDA, Regulatory Updates, Inspection Readiness, Clinical Strategy, Quality Systems

What does the move to QMSR and the implications of ICHE6(R3) mean for clinical stage biotechs?

June 25, 2025

In less than a year, two major updates to Quality regulations will go into effect in the European Union and United...

Clinical Strategy, Quality Systems, Data Integrity

Are you maximizing the value of your asset for out-licensing?

June 4, 2025

It is increasingly common for biotech companies to develop products to the point of Proof of Concept or late Phase 2...

Quality & Compliance

Clinical Readiness Checklist

October 29, 2024

John Klein outlines the key factors TriRadial utilizes that can play a critical role in bringing you into regulatory...

Outsourcing

Clinical Change Order Evaluation and Vendor Negotiations

October 29, 2024

Client Challenge Faced

Outsourcing

Considerations for Clinical Vendor Selection Process

October 29, 2024

Client Challenge Faced

Outsourcing

CTE 2021 Q&A

March 9, 2022

Raphaële Mary, one of TriRadial's Vendor Outsourcing Management experts, along with Alexandra Kemmer-Brück, Senior...

Quality & Compliance

Part 1 in the series "CAPA for non-Quality Clinical folks"

May 11, 2021

This video podcast with Leo Dodds provides a brief overview of the Corrective Action/Preventive Action (CAPA) lifecycle...

Quality & Compliance

Part 2 in the series "CAPA for non-Quality Clinical folks"

May 11, 2021

This video podcast builds off of the initial episode on the Corrective Action/Preventive Action (CAPA) process and...

Quality & Compliance

Part 3 of the series "CAPA for non-Quality Clinical folks"

May 11, 2021

This video podcast builds off of the second episode on the Corrective Action/Preventive Action (CAPA) process and...